Related Experiment Video
Updated: Sep 3, 2025

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014
Potential Anticancer Activities and Catalytic Oxidation Efficiency of Platinum(IV) Complex
Mohamed M El-Bendary1,2, Tamer S Saleh1,3, Mansour M Alomari1
1Department of Chemistry, College of Science, University of Jeddah, Jeddah 21589, Saudi Arabia.
A new platinum(IV) complex was synthesized and characterized. This platinum complex demonstrates significant cytotoxicity against various cancer cell lines, inducing apoptosis and necrosis, and shows catalytic activity in oxidation reactions.
Area of Science:
- Coordination Chemistry
- Materials Science
- Chemical Biology
Background:
- Platinum complexes are vital in cancer chemotherapy.
- Developing novel platinum(IV) complexes with enhanced properties is an active research area.
- Understanding structure-activity relationships is crucial for designing effective therapeutic agents.
Purpose of the Study:
- To synthesize and characterize a new platinum(IV) complex using chloroplatinic acid hydrate and pyridine-2-carbaldehyde-oxime.
- To evaluate the in vitro cytotoxicity of the synthesized platinum complex against various human cancer cell lines.
- To investigate the catalytic and luminescence properties of the novel platinum complex.
Main Methods:
- Synthesis of the platinum(IV) complex ([Pt(SCN)2(paO)2]) from H2PtCl6.xH2O and pyridine-2-carbaldehyde-oxime (paOH) in the presence of potassium thiocyanate.
- Characterization using FT-IR, UV-vis, NMR spectroscopy, elemental analysis, and single-crystal X-ray diffraction.
- In vitro cytotoxicity assays (IC50 determination), apoptosis/necrosis assays, cell cycle analysis, catalytic oxidation reactions, and luminescence studies.
Main Results:
- A novel Pt(IV) complex, [Pt(SCN)2(paO)2], was successfully synthesized and structurally elucidated.
- The complex exhibited significant in vitro cytotoxicity against colon (HCT116), liver (HepG2), breast (MCF-7), and erythroid (JK-1) cancer cell lines, with IC50 values ranging from 13 ± 3 to 22 ± 6 μM.
- Treatment with the complex induced apoptosis and necrosis, caused cell cycle arrest in the S phase, and demonstrated catalytic activity in benzyl alcohol oxidation.
Conclusions:
- The synthesized platinum(IV) complex possesses promising anti-cancer properties and potential applications in catalysis.
- The structural and cytotoxic data provide valuable insights for the development of new platinum-based chemotherapeutic agents.
- Further research into its mechanism of action and therapeutic potential is warranted.
More Related Videos
11:14Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
Published on: November 10, 2013
12:08Catalytic Reactions at Amine-Stabilized and Ligand-Free Platinum Nanoparticles Supported on Titania During Hydrogenation of Alkenes and Aldehydes
Published on: June 24, 2022
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Electron Transport Chain: Complex III and IV
Reduction of Alkenes: Asymmetric Catalytic Hydrogenation
The metal catalyst used can be either heterogeneous or homogeneous. When hydrogenation of an alkene generates a chiral center, a pair of enantiomeric products is expected to form. However, an enantiomeric excess of one of the products can be facilitated using an enantioselective reaction or an...